norgestimate has been researched along with norethindrone acetate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P | 1 |
Caubel, P; Lim, P; Ylikorkala, O | 1 |
Caubel, P; Lim, PC; Rozenberg, S | 1 |
Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
4 trial(s) available for norgestimate and norethindrone acetate
Article | Year |
---|---|
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction | 1999 |
Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Triglycerides | 2000 |
Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Topics: Adult; Aged; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progestins; Uterine Hemorrhage; Vasomotor System | 2001 |
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |